Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

CUSIP: 64135M105

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 5 signals
Share change
+9,228,460
SEC-reported price per share
$19.38
Number of holders
35
Value change
+$178,848,733
Number of buys
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
15,729,081

Security key

64135M105

Report period

Q4 2023

Institutions

35

Top holders

10

Ownership snapshot

Top reported holders of NGNE - Neurogene Inc. - Common Stock, $0.000001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
0/13
Latest evidence
18 Dec 2023
3/4/5 Highest disclosed value: $287,276 13 rows are not safely comparable across share classes. Showing 1-6 of 13 holder rows.

Quick read

BAKER BROS. ADVISORS LP has the largest disclosed position value at $287.3K.

0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAKER BROS. ADVISORS LP's linked filing trail.
Disclosed position value Top 3
BAKER BROS. ADVISORS LP $287.3K
Priti Patel $25.8K
Sean Michael Smith $15K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 13 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
3/4/5
Director, Former 10% Owner
mixed-class rows
$287,276
4,591,937 shares
mixed-class rows
18 Dec 2023
Priti Patel
3/4/5
Former Chief Medical Officer
class O/S missing
$25,850
37,313 shares
31 Mar 2023
Sean Michael Smith
3/4/5
Interim CFO, Prin Acct Off
class O/S missing
$14,990
21,637 shares
10 Aug 2023
Jonathan G. Drachman
3/4/5
President and CEO, Director
class O/S missing
350,000 shares
02 Aug 2022
Carl Walkey
3/4/5
Senior Vice President
class O/S missing
150,000 shares
02 Aug 2022
Donna Cochener
3/4/5
General Counsel, SVP Legal
class O/S missing
100,000 shares
02 Aug 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
35
Shares
9,233,865
Rows available
35
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
0
Q4 2023 holders
35
Holder diff
35
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .